Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.
Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P. Thalmensi J, et al. Among authors: liard c. Oncoimmunology. 2015 Nov 5;5(3):e1083670. doi: 10.1080/2162402X.2015.1083670. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141336 Free PMC article.
A DNA telomerase vaccine for canine cancer immunotherapy.
Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Julithe M, Bourre L, Keravel O, Clayette P, Huet T, Wain-Hobson S, Langlade-Demoyen P. Thalmensi J, et al. Among authors: liard c. Oncotarget. 2019 May 21;10(36):3361-3372. doi: 10.18632/oncotarget.26927. eCollection 2019 May 21. Oncotarget. 2019. PMID: 31164958 Free PMC article.
Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.
Pliquet E, Ruffie C, Escande M, Thalmensi J, Najburg V, Combredet C, Bestetti T, Julithe M, Liard C, Huet T, Wain-Hobson S, Tangy F, Langlade-Demoyen P. Pliquet E, et al. Among authors: liard c. Cancer Immunol Immunother. 2019 Apr;68(4):533-544. doi: 10.1007/s00262-018-2272-3. Epub 2019 Jan 17. Cancer Immunol Immunother. 2019. PMID: 30656384 Free PMC article.
Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumor.
Dosset M, Godet Y, Vauchy C, Beziaud L, Lone YC, Sedlik C, Liard C, Levionnois E, Clerc B, Sandoval F, Daguindau E, Wain-Hobson S, Tartour E, Langlade-Demoyen P, Borg C, Adotévi O. Dosset M, et al. Among authors: liard c. Clin Cancer Res. 2012 Nov 15;18(22):6284-95. doi: 10.1158/1078-0432.CCR-12-0896. Epub 2012 Oct 2. Clin Cancer Res. 2012. PMID: 23032748
Transcutaneous and intradermal vaccination.
Combadiere B, Liard C. Combadiere B, et al. Among authors: liard c. Hum Vaccin. 2011 Aug;7(8):811-27. doi: 10.4161/hv.7.8.16274. Epub 2011 Aug 1. Hum Vaccin. 2011. PMID: 21817854 Review.
21 results